Please provide your email address to receive an email when new articles are posted on . People whose sedentary time rose from age 11 to 24 years were more likely to have a progressively enlarged left ...
Ancora Heart kicked off a European clinical study for its device designed to directly repair an enlarged left ventricle from the inside, as a treatment for patients suffering from heart failure. The ...
Pivotal Trial to Evaluate Safety and Efficacy of AccuCinch® Ventricular Restoration System in Heart Failure Patients with Reduced Ejection Fraction SANTA CLARA, Calif.--(BUSINESS WIRE)--Ancora Heart, ...
About Ancora Heart Ancora Heart, Inc., based in Santa Clara, Calif., is dedicated to helping people with heart failure feel better and live longer. Ancora Heart has developed the AccuCinch Ventricular ...
Please provide your email address to receive an email when new articles are posted on . Ancora Heart Inc. announced that the FDA granted breakthrough device designation to its transcatheter left ...
After enrolling the first patient at the top of this year in a pivotal trial of its ventricle-reshaping heart failure treatment, Ancora Heart has netted $80 million in funding to carry its device ...
However, the hazards of transthoracic puncture and injection of the left ventricle preclude general acceptance of this method. Littmann and his associates, 3 in 1960, using a modified Seldinger 4 ...
Idiopathic premature ventricular contractions (PVCs) may cause subtle changes in left atrium (LA) structure and function. The authors of an article published in Cardiovascular Innovations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results